首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3134篇
  免费   206篇
  国内免费   149篇
  2024年   6篇
  2023年   57篇
  2022年   125篇
  2021年   251篇
  2020年   174篇
  2019年   221篇
  2018年   197篇
  2017年   142篇
  2016年   199篇
  2015年   257篇
  2014年   339篇
  2013年   337篇
  2012年   329篇
  2011年   281篇
  2010年   144篇
  2009年   108篇
  2008年   105篇
  2007年   81篇
  2006年   44篇
  2005年   38篇
  2004年   20篇
  2003年   11篇
  2002年   9篇
  2001年   4篇
  2000年   4篇
  1997年   2篇
  1994年   1篇
  1989年   1篇
  1959年   2篇
排序方式: 共有3489条查询结果,搜索用时 0 毫秒
961.
962.
Lv PP  Wei W  Yue H  Yang TY  Wang LY  Ma GH 《Biomacromolecules》2011,12(12):4230-4239
Clinical application of paclitaxel (PTX) is limited because of its poor solubility in aqueous media. To overcome this hurdle, we devised an oral delivery system by encapsulating PTX into N-((2-hydroxy-3-trimethylammonium) propyl) chitosan chloride (HTCC) nanoparticles. These nanoparticles were small (~130 nm), had a narrow size distribution, and displayed high loading efficiency owing to the homogeneous distribution of PTX nanocrystals. The matrix hydrophilicity and porous structure of the obtained nanoparticles accelerated their degradation and improved drug release. In vitro and in vivo transport experiments had proved that the presence of positive charges enhanced the intestinal permeability of these nanoparticles. Further in vitro experiment of cytotoxicity showed that the PTX-loaded HTCC nanoparticle (HTCC-NP:PTX) was more effective than native PTX owing to enhanced cellular uptake. Drug distribution in tissues and in vivo imaging studies confirmed the preferred accumulation of HTCC-NP:PTX in subcutaneous tumor tissue. Subsequent tumor xenograft assays demonstrated the promising therapeutic effect of HTCC-NP:PTX on inhibition of tumor growth and induction of apoptosis in tumor cells. Additional investigation into side effects revealed that HTCC-NP:PTX caused lower Cremophor EL-associated toxicities compared with Taxol. These results strongly supported the notion that HTCC nanoparticle (HTCC-NP) is a promising candidate as an oral carrier of PTX for cancer therapy.  相似文献   
963.
964.
根据Myostatin基因突变可导致肌肉量激增而产生"双肌"表型的特点,构建绵羊Myostatin基因置换型敲除栽体.利用LA-PCR技术成功地扩增得到绵羊Myostatin基因同源臂序列,其中同源长臂4.9kb,包括全部的exonl,intronl,exon2及部分启动子和大部分intron2;同源短臂1.1kb,包括部分exon3和31非翻译区序列,将二者连入PloxpⅡ正负筛选敲除骨架载体,利用骨架载体上Neo基因替代Myostatin基因的exon3,从而成功构建专门针对Myostatin第3外显子区域缺失的置换型敲除载体PloxpⅡ-OVIS-MSTN.酶切和测序鉴定证明载体构建正确,为后续获得绵羊Myostatin基因缺失型体细胞株奠定试验基础.  相似文献   
965.
针对目前转基因产品检测标准物质缺乏的难题,构建适于转基因油菜RT73品系特异性检测的标准分子pEASY-RT73.其包含转基因油菜RT73品系3'端侧翼序列,油菜内标准基因HMG和PEP片段.对其在定性和定量检测中的适用性进行了实验室内部验证,结果表明,标准分子pEASY-RT173高度特异于转基因油菜RT73品系.以标准分子为标准品的普通PCR扩增中,3个目标片段的检测下限(LOD)均为10拷贝.实时荧光PCR检测的LOD均为25拷贝,定量下限(LOQ)均为50拷贝.以标准分子为标准品构建的标准曲线反应效率介于0.96-1.02间,相关系数均大于0.999.分别以PEP和HMG为内标准基因对5个盲样的测试结果显示,测量值与设定值间偏差(Bias)介于-14.13%-14.29%间,SD小于0.20,RSD小于18.0%.因此,标准分子pEASY-RT73可很好地替代植物来源阳性标准品用于转基因油菜Rt73及其来源产品品系特异性检测.  相似文献   
966.
旨在构建DC-SIGN胞外区基因原核表达质粒,诱导蛋白表达并制备多克隆抗体。用PCR的方法扩增编码DC-SIGN胞外区的基因序列,将其克隆到原核表达载体pET-28a(+)中,利用大肠杆菌表达系统表达DC-SIGN胞外区蛋白,用H is抗体做W estern Blotting鉴定目的蛋白的免疫原性。用纯化的DC-SIGN胞外区蛋白免疫日本大耳白兔,制备多克隆抗体。通过酶联免疫吸附试验(ELISA)检测抗体效价,免疫荧光法检测其特异性。结果显示,原核表达载体pET-28 a(+)-DC-SIGN胞外区基因成功构建,可在大肠杆菌BL21(DE3)中高效表达,获得相对分子质量约20 kD的DC-SIGN胞外区蛋白,经Westernb lotting鉴定为正确。纯化后的蛋白免疫大耳白兔,制备的多克隆抗体具有较强免疫原性和特异性。本研究得到了纯化的DC-SIGN胞外区蛋白,并制备了具有特异性和高效价的抗体,为研究DC-SIGN生物学功能提供试验基础。  相似文献   
967.
Protein phosphorylation is one of the most common post-translational modification processes that play an essential role in regulating protein functionality.The Helicoverpa armigera single nucleopolyhedrovirus (HearNPV) orf2-encoded nucleocapsid protein HA2 participates in orchestration of virus-induced actin polymerization through its WCA domain,in which phosphorylation status are supposed to be critical in respect to actin polymerization.In the present study,two putative phosphorylation sites (232Thr and 2...  相似文献   
968.
To investigate the role of mechanical pressure on cartilage thickness and type II collagen synthesis, and the role of G protein in that process, in vitro organ culture of mandibular cartilage was adopted in this study. A hydraulic pressure-controlled cellular strain unit was used to apply hydrostatic pressurization to explant cultures. The explants were compressed by different pressure values (0 kPa, 100 kPa, and 300 kPa) after pretreatment with or without a selective and direct antagonist (NF023) for the G proteins. After 4, 8 and 12 h of cell culture under each pressure condition, histological sections of the explants were stained with hematoxylin-eosin to investigate the thickness of the cartilage. Immunohistochemical staining was used to observe type II collagen expressions. The results showed that a hydrostatic pressure of 100 kPa significantly reduced the thickness of the proliferative layer in condylar cartilage without affecting the thickness of the transitional layer. Hydrostatic pressures of 100 kPa and 300 kPa significantly enhanced the synthesis of type II collagen. G proteins are involved not only in the proliferation and differentiation of condylar cartilage regulated by prolonged pressure, but also in the process of collagen production in condylar cartilage stimulated by pressure.  相似文献   
969.
We have recently identified a new class III chitinase from pomegranate seeds (PSC). Interestingly, this new chitinase naturally binds calcium ions with high capacity and low affinity, suggesting that PSC is a Ca-storage protein. Analysis of the amino acid sequence showed that this enzyme is rich in acidic amino acid residues, especially Asp, which are responsible for calcium binding. Different from other known chitinases, PSC is located in the stroma of amyloplasts in pomegranate seeds. Transmission electron microscopy (TEM) analysis indicated that the embryonic cells of pomegranate seeds are rich in calcium ions, most of which are distributed in the stroma and the starch granule of the amyloplasts, consistent with the above idea that PSC is involved in calcium storage, a newly non-defensive function.  相似文献   
970.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号